hypophys
inflammatori
process
pituitari
gland
often
involv
contigu
structur
classifi
primari
secondari
form
primari
form
character
inflammatori
process
confin
pituitari
gland
without
well
identifi
etiolog
agent
secondari
form
pituitari
inflammatori
process
trigger
definit
etiolog
infect
pharmacolog
agent
pituitari
involv
gener
known
system
diseas
tabl
basi
histopatholog
find
primari
hypophys
divid
five
type
lymphocyt
hypophys
lyh
granulomat
hypophys
xanthomat
hypophys
necrot
hypophys
plasmacyt
hypophys
still
consid
truli
distinct
entiti
author
differ
express
diseas
other
possibl
occurr
mix
form
lyh
frequent
form
primari
hypophys
character
extens
infiltr
pituitari
lymphocyt
plasma
cell
involv
structur
classifi
lymphocyt
adenohypophys
process
involv
anterior
pituitari
lymphocyt
infundibuloneurohypophys
involv
posterior
lobe
infundibulum
lymphocyt
panhypophys
involv
global
anterior
posterior
lobe
infundibulum
new
form
primari
hypophys
recent
describ
plasmacyt
hypophys
character
massiv
infiltr
pituitari
gland
andor
stalk
numer
plasma
cell
diseas
also
call
hypophys
includ
togeth
sever
diseas
spectrum
diseas
tabl
autoimmun
hypophys
still
consid
rare
case
pituitari
autoimmun
increasingli
recogn
autoimmun
pathogenesi
lyh
propos
goudi
pinkerton
describ
occurr
lyh
young
woman
show
postpartum
amenorrhea
hypothyroid
die
month
deliveri
acut
hypoadren
follow
surgeri
appendicectomi
autopt
find
show
massiv
lymphoplasmacyt
infiltr
pituitari
thyroid
gland
adren
atrophi
actual
first
descript
made
simmond
pituitari
autopsi
subsequ
case
panhypopituitar
due
pituitari
atrophi
diffus
fibrosi
moder
lymphocyt
infiltr
lymphocyt
collect
small
foci
describ
rupp
paschki
howev
author
could
classifi
disord
autoimmun
concept
endocrin
autoimmun
introduc
sever
year
later
hashimoto
thyroid
first
descript
frequenc
case
report
lyh
literatur
increas
time
per
million
per
year
incid
estim
deriv
data
buxton
robertson
may
well
underestim
present
incid
diseas
caturegli
et
al
review
case
case
diagnos
basi
clinic
histopatholog
find
magnet
reson
imag
mri
detect
pituitari
antibodi
number
new
case
describ
increas
consider
year
onward
favour
grow
gener
awar
medic
commun
condit
moreov
recent
increas
use
noninvas
pituitari
imag
method
investig
presenc
pituitari
antibodi
suspect
patient
well
patholog
find
pituitari
specimen
patient
undergo
transsphenoid
surgeri
greatli
contribut
increas
diagnosi
lyh
howev
even
sever
mani
case
appear
literatur
year
present
true
preval
incid
lyh
like
underestim
preval
primari
hypophysit
approxim
annual
incid
million
probabl
underestim
fact
databas
popul
case
biopsyproven
suspect
lyh
includ
diseas
often
misdiagnos
consid
especi
patient
subclin
phase
lyh
common
form
primari
hypophys
consid
form
lyh
lyh
frequent
women
especi
last
semest
pregnanc
postpartum
period
femalemal
ratio
howev
case
occur
outsid
pregnanc
increas
recent
year
mean
age
diagnosi
usual
year
women
year
men
case
describ
children
elderli
among
ethnic
factor
first
seri
patient
caucasian
japanes
ratio
recent
reevalu
caturegli
et
al
lower
ratio
consider
increas
case
japanes
affect
even
still
inferior
caucasian
percentag
frequent
describ
hla
allel
first
seri
e
recent
found
commonli
present
patient
lyh
histopatholog
find
suggest
autoimmun
process
overlap
describ
endocrin
gland
specimen
usual
deriv
autopsi
pituitari
surgeri
pituitari
biopsi
still
consid
gold
diagnost
standard
show
massiv
pituitari
infiltr
lymphocyt
b
lymphocyt
mainli
class
plasma
cell
macrophag
group
aggreg
surround
atroph
acini
pituitari
cell
lymphocyt
sometim
arrang
lymphoid
follicl
germin
center
wherea
area
reactiv
fibrosi
shown
remain
pituitari
tissu
fig
germin
centr
frequent
consist
posit
b
cell
locat
central
peripher
cell
recent
suggest
two
distinct
entiti
lyh
distinguish
basi
preval
tregulatori
cell
cell
helper
cell
effector
mani
human
autoimmun
diseas
one
entiti
demonstr
autoimmun
process
domin
lack
tregulatori
cell
anoth
form
appear
process
tregulatori
cell
control
immun
respons
may
selftarget
rather
foreign
target
infect
agent
immunochemistri
also
show
numer
mast
cell
local
proxim
capillari
thu
favour
permeabl
angiogenesi
contribut
perpetu
inflammatori
autoimmun
process
natur
histori
lyh
similar
autoimmun
diseas
progress
sever
stage
cycl
remiss
relaps
good
respons
immunosuppress
therapi
possibl
spontan
remiss
progress
establish
chronic
stage
like
relat
sever
damag
hypothalamicpituitari
cell
relationship
cytokin
produc
site
inflammatori
autoimmun
process
hpa
axi
fact
cytokin
usual
stimul
hpa
axi
lead
hyperactiv
hyperproduct
crh
avp
stimul
directli
indirectli
adren
cortisol
secret
contribut
limit
extinct
autoimmun
process
immun
aggress
caus
sever
damag
pituitari
cell
mostli
acthsecret
cell
earli
stage
lyh
consequ
impair
secret
cortisol
may
abl
interrupt
immun
process
contribut
perpetu
aggress
pituitari
cell
progress
stabl
pituitari
dysfunct
condit
even
sever
autoimmun
process
involv
hypothalamu
damag
crh
avpsecret
cell
thu
prevent
stimulatori
effect
cytokin
hpa
perpetu
inflammatori
process
contrast
pituitari
cell
damag
transient
mostli
relat
pituitari
edema
hyperactiv
local
cytokin
hpa
axi
consequ
cortisol
hyperproduct
may
interrupt
immun
process
recoveri
pituitari
function
fig
patient
lyh
often
famili
histori
autoimmun
lyh
show
close
associ
autoimmun
diseas
autoantibodi
endocrin
gland
configur
case
autoimmun
polyendocrin
syndrom
ap
associ
describ
sever
endocrin
nonendocrin
diseas
commonli
observ
associ
autoimmun
thyroid
diseas
among
ap
type
diseas
fall
ap
type
fig
sever
autoimmun
diseas
correl
particular
human
leukocyt
antigen
hla
allel
hla
type
small
number
patient
lyh
result
far
inconclus
previou
studi
patient
predomin
allel
found
hla
less
frequent
hla
pituitari
cell
none
patient
show
hla
class
ii
molecul
often
express
tissu
attack
autoimmun
process
howev
previous
specifi
recent
studi
heaney
et
al
investig
relationship
specif
hla
marker
lyh
patient
sporad
lyh
patient
develop
hypohys
treatment
ctla
antibodi
melanoma
compar
result
obtain
patient
pituitari
mass
normal
control
patient
sporad
lyh
found
express
express
patient
contrast
none
four
patient
acquir
ctl
ab
hypophys
exhibit
exhibit
marker
compar
result
patient
anoth
pituitari
mass
odd
ratio
patient
lyh
express
marker
higher
patient
anoth
sellar
mass
result
hand
support
autoimmun
pathogenesi
lyh
suggest
test
may
assist
diagnosi
patient
atyp
lyh
acutesubacut
phase
lyh
character
pituitari
massrel
symptom
sign
frequent
accompani
symptom
pituitari
failur
similar
nonfunct
pituitari
adenoma
particular
regard
symptom
mass
effect
headach
develop
frequent
occur
dramat
fashion
symptom
visual
impair
nausea
vomit
also
present
usual
symptom
phase
evok
pituitari
edema
extrasellar
expans
pituitari
infiltr
lymphocyt
plasma
cell
even
pituitari
biopsi
still
consid
gold
diagnost
standard
lyh
symptom
mass
effect
present
invas
procedur
alway
consent
patient
thu
patient
acutesubacut
phase
presumpt
diagnosi
lyh
could
made
basi
clinic
featur
imag
laboratori
find
moreov
regard
isol
multipl
pituitari
hormon
defici
stage
sometim
misdiagnos
patient
clinic
asymptomat
howev
phase
acth
frequent
earliest
pituitari
hormon
defici
usual
associ
hyperprolactinemia
rare
case
rapid
sever
diseas
progress
may
caus
sever
secondari
adren
insuffici
consequ
sudden
death
multifactori
etiolog
suggest
hyperprolactinemia
affect
approxim
onethird
patient
caus
amenorrheagalattorrhea
women
sexual
dysfunct
men
case
due
decreas
dopamin
deliveri
anterior
pituitari
relat
stalk
compress
pituitari
suprasellar
inflammatori
mass
alter
dopamin
receptor
hyperprolactinemia
also
present
patient
without
involv
extrasellar
structur
case
diffus
lymphocyt
infiltr
pituitari
gland
could
determin
escap
prl
circul
secondari
massiv
cellular
destruct
howev
prl
could
directli
releas
immun
cell
infiltr
gland
consid
relationship
immun
system
prl
whatev
caus
high
level
prl
could
contribut
perpetu
immun
process
lyh
wellknown
proinflammatori
immunogen
effect
hormon
establish
chronic
phase
pituitari
fibrosi
atrophi
accompani
mono
pluritropin
defici
secondari
impair
respect
target
gland
function
acth
defici
may
thu
tempor
follow
lh
fsh
gh
tsh
rare
prl
defici
possibl
panhypopituitar
develop
symptom
sign
usual
correl
sever
pituitari
enlarg
suggest
pituitari
hormon
defici
could
due
earli
direct
attack
autoimmun
process
pituitarysecret
cell
rather
later
pituitari
histopatholog
alter
patient
infundibuloneurohypopys
central
diabet
insipidu
cdi
usual
present
patient
lyh
cdi
sometim
present
even
absenc
radiolog
find
lymphocyticinfundibuloneurohypophys
recent
pituitari
work
group
german
societi
endocrinolog
conduct
nationwid
retrospect
crosssect
cohort
studi
clinic
endocrinolog
featur
primari
hypophys
german
patient
result
partial
contrast
literatur
headach
weight
gain
frequent
nonendocrin
symptom
associ
hypophys
pregnanc
observ
femal
patient
diabet
insipidu
found
patient
present
hypogonadotrop
hypogonad
frequent
endocrin
failur
wherea
gh
defici
less
frequent
granulomat
hypophys
associ
sever
symptom
lyh
even
german
studi
compris
data
sever
form
primari
hypophysyti
lyh
discrep
result
german
popul
data
literatur
seem
indic
environment
factor
may
influenc
clinic
featur
hypophysyti
affect
patient
previous
specifi
pituitari
biopsi
gold
diagnost
standard
lyh
howev
invas
procedur
alway
consent
patient
magnet
reson
imag
mri
may
help
diagnosi
lyh
differenti
diseas
case
pituitari
mass
particular
pituitari
tumor
even
imag
find
sometim
tend
overlap
limit
correct
differenti
diagnosi
patient
lyh
mri
usual
reveal
homogen
pituitari
enlarg
symmetr
suprasellar
extens
compress
displac
chiasma
thicken
deviat
stalk
german
patient
thicken
pituitari
stalk
prevail
neuroradiolog
sign
found
affect
patient
gadolinium
mri
show
prompt
intens
homogen
enhanc
mass
strip
enhanc
tissu
along
dura
madr
socal
dural
tail
patient
process
involv
neurohypophysi
bright
spot
usual
lost
subclin
clinic
cdi
usual
present
case
empti
sella
repres
unusu
featur
lyh
mri
particularli
later
stage
diseas
possibl
final
outcom
empti
sella
mri
describ
lyh
shehan
syndrom
ss
syndrom
due
pituitari
ischemia
sever
postpartum
hemorrag
may
character
empti
sella
pituitari
mri
find
prl
defici
postpartum
lactat
failur
lead
consid
possibl
diagnosi
ss
howev
alway
possibl
differenti
diseas
lyh
pituitari
ischemia
occur
ss
consequ
cellular
damag
may
trigger
autoimmun
process
pituitari
level
contribut
perpetu
hypopituitar
affect
women
patient
pituitari
adenoma
mri
commonli
reveal
endosellar
mass
unilater
sellar
floor
depress
asymmetr
suprasellar
extens
controlater
deviat
stalk
gadolinium
enhanc
pituitari
mass
slight
delay
inhomogen
usual
dural
tail
absent
bright
spot
preserv
tabl
scholarli
criteria
alway
provid
correct
differenti
diagnosi
contribut
argument
gutemberg
et
al
year
ago
propos
new
radiolog
score
distinguish
autoimmun
hypophys
notsecret
pituitari
adenoma
decid
appropri
therapeut
choic
particular
author
analyz
multipl
logist
regress
eight
featur
contribut
significantli
classifi
pituitari
mass
pituitari
adenoma
hypophys
relat
age
pregnanc
pituitari
mass
volum
symmetri
signal
intens
signal
intens
homogen
gadolinium
posterior
pituitari
bright
spot
presenc
stalk
size
mucos
swell
score
suggest
diagnosi
adenoma
wherea
score
suggest
diagnosi
autoimmun
hypophys
use
score
result
signific
improv
differenti
diagnosi
adenoma
autoimmun
hypophys
compar
result
obtain
assess
singl
paramet
howev
despit
use
score
suggest
gutenberg
et
al
diffferenti
diagnosi
mri
lyh
pituitari
mass
still
problemat
also
confirm
import
paper
publish
report
result
experi
popul
patient
submit
mri
presenc
sellar
parasellar
mass
famini
et
al
show
five
patient
lyh
present
panhypopituitar
three
five
initi
diagnos
macroadenoma
result
confirm
one
hand
rariti
lyh
respect
sellar
parasellar
mass
origin
investig
mri
hand
also
possibl
misdiagnosi
also
follow
criteria
suggest
gutemberg
et
al
first
method
use
detect
apa
complement
consumpt
test
first
report
method
never
employ
laboratori
use
method
immunoblot
assay
radioligand
bind
indirect
immunofluoresc
immunoblot
method
util
homogen
human
autopsi
pituitari
tissu
substrat
identifi
antigen
target
apa
method
crock
show
serum
antibodi
kda
pituitari
cytosol
protein
present
patient
biopsyproven
lyh
patient
suspect
lyh
includ
patient
isol
acth
defici
patient
hypopituitar
associ
autoimmun
diseas
femal
sheehan
syndrom
subsequ
crock
et
al
identifi
kda
pituitari
cytoplasmat
protein
ubiquit
express
enzym
consid
antibodi
antigen
marker
lyh
interestingli
express
pituitari
placenta
thu
provid
theoret
basi
strong
associ
pituitari
autoimmun
pregnanc
subsequ
studi
suggest
antibodi
enolas
consid
specif
lyh
frequent
present
patient
lyh
also
patient
hypopituitar
secondari
pituitari
adenoma
pituitari
diseas
techniqu
radioligand
bind
assay
led
sever
studi
organspecif
autoimmun
diseas
method
abl
detect
autoantibodi
pituitari
gland
specif
factor
patient
biopsyproven
lyh
patient
isol
acth
defici
autoantibodi
detect
patient
suspect
lyh
linh
antigh
antibodi
present
patient
lyh
patient
autoimmun
diseas
patient
pituitari
adenoma
show
reactiv
either
autoantibodi
found
patient
rheumatoid
arthriti
howev
inform
avail
pituitari
hormon
function
latter
patient
possibl
know
present
whether
result
due
lack
specif
autoantibodi
marker
high
diagnost
sensit
subtl
pituitari
dysfunct
immunofluoresc
method
one
wide
employ
method
detect
apa
howev
clinic
applic
routin
diagnosi
still
debat
sever
methodolog
problem
main
problem
method
use
pituitari
section
obtain
varieti
speci
varieti
condit
substrat
particular
apa
detect
cryostat
section
pituitari
gland
obtain
human
primat
rodent
process
fluorescein
isothiocyan
conjug
goat
antihuman
ig
sera
influenc
human
anim
pituitari
substrat
sensit
specif
immunofluoresc
method
still
discuss
fact
immunofluoresc
detect
apa
patient
suspect
biopsyproven
lyh
also
patient
nonautoimmun
pituitari
diseas
pituitari
adenoma
empti
sella
syndrom
author
compar
result
obtain
use
either
human
pituitari
gland
anim
pituitari
substrat
affirm
result
anim
substrat
inconclus
lower
sensit
specif
human
substrat
convers
author
obtain
quit
reliabl
result
use
anim
human
section
final
reliabl
result
obtain
use
adren
hypothalam
tissu
anim
substrat
search
immunofluoresc
antibodi
key
adren
enzym
avpsecret
cell
patient
clinic
subclin
addison
diseas
cdi
respect
thu
antibodi
consid
good
specif
sensibl
sometim
predict
marker
addison
diseas
cdi
respect
take
account
previou
argument
aim
improv
specif
sensit
immunofluresc
method
establish
characterist
satisfi
process
immunofluoresc
result
particular
consid
reliabl
result
immunofluoresc
apa
detect
use
substrat
cryostat
section
pituitari
young
baboon
titr
higher
cutoff
valu
associ
particular
kind
immunostain
pattern
follow
criteria
search
apa
immunofluoresc
larg
cohort
adult
children
idiopath
ghd
patient
idiopath
hypogonadotrop
hypogonad
result
studi
suggest
apa
present
high
titr
immunostain
pattern
involv
select
pituitari
cell
could
consid
good
marker
autoimmun
isol
hypopitutar
antibodi
character
fourlay
doubl
fluorochrom
immunofluoresc
test
second
step
pituitari
section
test
consecut
patient
serum
found
posit
apa
first
step
anim
pituitari
hormon
antiserum
differ
color
antiig
conjug
human
anim
serum
respect
green
fitc
red
rhodamin
allow
direct
visual
assess
whether
patient
serum
anim
antihormon
serum
stain
differ
pituitari
cell
allow
identif
kind
pituitari
cell
target
apa
patient
previous
found
posit
antibodi
method
could
verifi
pituitarysecret
cell
target
apawer
somatotroph
patient
gh
defici
gonadotroph
patient
hypogonadotrop
hypogonad
shown
patient
ap
isol
autoimmun
endocrin
diseas
risk
complex
autoimmun
diseas
unveil
search
respect
autoantibodi
concern
recent
studi
evalu
predict
valu
apa
antihypothalamu
antibodi
aha
detect
simpl
indirect
immunofluoresc
occurr
subsequ
hypopituitar
purpos
plan
investig
time
relat
variat
longitudin
studi
patient
autoimmun
polyendocrin
syndrom
ap
posit
antibodi
normal
pituitari
function
diagnosi
result
show
case
presenc
aha
apa
associ
select
combin
hypopituitar
suggest
autoimmun
process
involv
hypothalamu
pituitari
could
respons
secondari
pituitari
dysfunct
patient
hand
find
apa
high
titr
immunostain
involv
pituitari
cell
abl
predict
occurr
subsequ
hypopituitar
followup
year
patient
ap
without
pituitari
dysfunct
diagnosi
moreov
character
pituitari
cell
target
apa
patient
isol
autoimmun
diseas
posit
antibodi
start
without
pituitari
dysfunct
may
help
forese
kind
subsequ
hypopituitar
fact
detect
apa
doubl
immunofluoresc
select
direct
gonadotroph
corticotroph
thyrotroph
somatotroph
start
follow
followup
correspond
pituitari
hormon
defici
recent
ascertain
respons
hypothalamu
pituitari
pituitari
hormon
defici
patient
autoimmun
hypophys
posit
apa
italian
autoimmun
hypophys
network
group
perform
studi
patient
search
antihypothalamu
antibodi
sera
posit
aha
detect
immunofluoresc
retest
doubl
immunofluoresc
identifi
hypothalam
cell
target
antibodi
result
show
antibodi
direct
toward
argininevasopressinsecret
cell
avpc
also
toward
releas
cell
particular
detect
aha
target
crhsecret
cell
patient
ghacth
defici
apa
specif
direct
ghsecret
cell
suggest
pluritropin
defici
patient
lyh
may
due
combin
autoimmun
aggress
pituitari
hypothalam
level
regard
relationship
pituitari
autoimmun
pregnanc
recent
describ
year
old
woman
present
lactat
failur
deliveri
growth
hormon
prolactin
defici
subsequ
sever
primari
autoimmun
hypothyroid
immunolog
studi
reveal
presenc
apa
identifi
target
gh
prolactinsecret
cell
doubl
immunofluoresc
elev
level
antithyroglobulin
antiperoxidas
antibodi
subsequ
appear
thyroid
dysfunct
first
observ
autoimmun
hypopituitar
involv
growth
hormon
prolactin
secret
patient
lactat
failur
deliveri
subsequ
follow
sever
primari
autoimmun
hypothyroid
thu
fall
unusu
autoimmun
polyendocrin
syndrom
type
second
similar
case
recent
publish
iwama
et
al
pregnanc
may
also
favour
transit
potentialsubclin
clinic
stage
autoimmun
hypothalamicpituitari
diseas
recent
studi
two
women
posit
avpcab
pregnanc
without
clinic
cdi
becam
pregnant
month
first
observ
behavior
postpituitari
function
avpcab
immunofluoresc
evalu
baselin
pregnanc
year
deliveri
avpcab
present
lowmiddl
titr
baselin
patient
show
titr
increas
pregnanc
one
patient
deliveri
one
develop
clinic
overt
cdi
therapi
ddavp
caus
prompt
clinic
remiss
therapi
definit
stop
month
post
partum
period
respect
avpcab
disappear
accompani
stabl
postpituitari
function
recoveri
persist
end
followup
result
indic
determin
avpcab
advis
patient
autoimmun
diseas
plan
pregnanc
could
consid
good
predict
marker
gestat
postpartum
autoimmun
cdi
monitor
avpcab
titr
postpituitari
function
pregnanc
patient
may
allow
earli
diagnosi
cdi
earli
replac
therapi
could
induc
disappear
antibodi
consequ
complet
remiss
autoimmun
cdi
interest
question
whether
antipituitari
antibodi
chang
pituitari
target
life
span
consequ
chang
kind
pituitari
hormon
defici
concern
conduct
longitudin
studi
pituitari
function
apa
immunofluresc
children
appar
idiopath
isol
gh
defici
ghd
treat
replac
rgh
therapi
childhood
transit
age
pituitari
function
apa
detect
investig
start
rgh
therapi
stop
therapi
transit
age
sera
patient
posit
apa
process
doubl
immunofluoresc
identifi
pituitari
target
diagnosi
patient
apa
posit
target
somatotroph
group
eight
apa
neg
group
retest
therapi
patient
group
persist
apa
posit
remain
four
becam
apa
neg
recoveri
pituitari
function
patient
group
persist
apa
neg
still
show
ghd
patient
persist
apa
posit
eight
confirm
ghd
show
apa
still
target
somatotroph
wherea
four
show
apa
target
gonadotroph
associ
hypogonadotrop
hypogonad
hh
result
suggest
possibl
remiss
autoimmun
ghd
diagnos
childhood
may
occur
patient
posit
middl
higher
titr
diagnosi
gh
replac
therapi
apa
may
shift
target
transit
period
especi
somatotroph
gonadotroph
thu
earli
character
apa
doubl
immunofluoresc
advis
apa
posit
ghd
patient
show
delay
puberti
allow
earli
diagnosi
appropri
therapi
thu
prevent
progress
toward
clinic
overt
hh
final
search
apa
patient
idiopath
hyperprolactinemia
may
help
disclos
possibl
occurr
autoimmun
hypophys
case
find
apa
high
titr
associ
acth
gh
defici
suggest
diagnosi
lyh
conclus
spite
diffus
use
immunofluoresc
method
result
appear
literatur
far
often
conflict
particularli
due
use
differ
human
anim
substrat
howev
think
improv
specif
sensit
method
may
obtain
exclud
low
titr
confound
immunostain
pattern
procedur
may
allow
reliabl
result
diagnos
least
suspect
pituitari
autoimmun
also
use
anim
substrat
especi
result
valid
second
step
fourlay
doubl
immunofluoresc
think
search
apa
particular
condit
may
help
avoid
underestim
autoimmun
hypophys
thu
suggest
possibl
presenc
apa
investig
patient
appar
idiopath
hypopituitar
especi
associ
autoimmun
diseasesin
patient
hyperprolactinemia
without
pituitari
adenoma
mri
without
hypothyroid
associ
iatrogen
causesin
patient
hypoprolactinemia
postpartum
lactat
failurein
patient
empti
sellain
patient
previou
traumat
brain
injuri
infecti
meningitisin
patient
treat
monoclon
antibodi
sever
type
tumorin
patient
syndromewhen
apa
detect
high
titr
particular
immunofluoresc
pattern
patient
pituitari
mri
yet
perform
complet
evalu
pituitari
function
perform
discov
pituitari
impair
even
subclin
stagein
case
search
antihypothalamu
antibodi
may
help
ascertain
occurr
autoimmun
process
involv
select
hypothalam
cell
associ
pituitari
autoimmun
new
form
primari
hypophys
strictli
correl
lyh
recent
describ
plasmacyt
hypophys
diseas
also
call
hypophys
includ
sever
diseas
spectrum
diseas
increasingli
recogn
syndrom
unknown
etiolog
compris
collect
disord
share
specif
patholog
serolog
clinic
featur
commonli
share
featur
includ
tumorlik
swell
involv
organ
lymphoplasmacyt
infiltr
enrich
plasma
cell
variabl
degre
fibrosi
moreov
elev
serum
concentr
usual
found
sever
organ
may
affect
disord
frequent
present
pancreat
scleros
sialoaden
associ
entiti
describ
scleros
cholang
orbit
inflammatori
pseudotumor
dacryoaden
aortiti
periaort
lung
diseas
mesenter
riedel
thyroid
kidney
diseas
hypophys
particular
relat
hypophys
initi
diagnos
clinic
set
woman
inflammatori
pseudotumor
affect
salivari
gland
pancrea
retroperitoneum
also
patholog
examin
man
histori
scleros
pancreat
cholang
subsequ
total
case
biopsi
proven
clinic
suspect
hypophys
report
case
recent
describ
form
hypophys
character
massiv
infiltr
pituitari
gland
andor
stalk
numer
plasma
cell
inflammatori
pituitari
process
misdiagnos
mimic
clinic
imag
featur
sellar
parasellar
tumor
follow
criteria
propos
leporati
et
al
hypophys
character
follow
featur
serum
concentr
mgdl
involv
organ
infiltr
plasma
cell
involv
tissu
favour
respons
glucocorticoid
treatment
hypophys
commonli
present
men
older
age
frequent
find
anterior
pituitari
enlarg
acut
acth
defici
process
involv
particularli
pituitari
gland
pituitari
stalk
thicken
loss
bright
spot
process
involv
extrasellar
structur
case
cdi
may
observ
major
affect
patient
particular
case
hypophys
recent
describ
hattori
et
al
affect
patient
present
loss
bright
spot
pituitari
stalk
thicken
brain
mri
without
cdi
anterior
pituitari
dysfunct
moreov
show
high
serum
level
without
coexist
diseas
infiltr
lymphocyt
plasmacel
posterior
lobe
frequent
show
surfac
alter
anterior
lobe
observ
biopsi
either
anterior
posterior
pituitari
lobe
author
suggest
relat
hypophys
often
unrecogn
especi
asymptomat
phase
regard
cdi
frequent
observ
form
hypophysyti
found
previou
studi
patient
lyh
associ
cdi
posit
avpcab
without
typic
sign
mri
infundibuloneurohypophys
suggest
direct
autoimmun
attack
avpsecret
cell
could
respons
cdi
follow
find
consid
avpcab
may
belong
think
search
antibodi
patient
hypophys
could
advis
clarifi
role
antibodi
cdi
secondari
form
autoimmun
drugrel
hypophys
recent
describ
relat
treatment
cytotox
tlymphocyteassoci
block
antibodi
recent
review
faje
summar
clinic
present
treatment
biolog
insight
hypophys
secondari
immunotherapi
therapi
frequent
employ
treatment
melanoma
malign
sever
autoimmun
side
effect
agent
describ
term
immunerel
advers
event
ira
includ
multipl
endocrinopathi
among
immunetarget
cancer
therapyrel
hypophys
recent
recogn
endocrin
ira
fact
recent
report
observ
patient
develop
lyh
autoimmun
diseas
treatment
block
agent
ipulimumab
suggest
possibl
correl
lyh
suggest
block
antibodi
may
act
deplet
tregulatori
cell
anoth
studi
antitumor
autoimmun
effect
agent
result
direct
activ
effector
cell
context
futur
studi
plan
investig
whether
microsatellit
polymorph
gene
shown
autoimmun
diseas
could
associ
develop
lyh
clinic
featur
includ
pituitari
dysfunct
mri
form
similar
lyh
case
electrolyt
alter
hyponatremia
also
describ
usual
follow
cessat
therapi
normal
pituitari
morpholog
followup
mri
return
clinic
baselin
condit
observ
spontan
earli
treatment
highdos
corticosteroid
predict
factor
onset
hypophys
patient
treat
immunotherapi
remain
present
unknown
often
present
insidi
subtl
symptom
lifethreaten
complic
especi
relat
possibl
acut
hypocortisol
thu
imper
form
distinguish
pituitari
metastas
melanoma
malign
close
clinic
observ
patient
progress
must
made
physician
particular
cogniz
overal
clinic
radiolog
pictur
form
hypophys
treat
patient
receiv
ipolimumab
similar
drug
effect
pituitari
avoid
possibl
sever
complic
unusu
present
lyh
present
diseas
mimick
featur
lyh
may
delay
diagnosi
possibl
damag
affect
patient
due
untim
inappropri
therapi
report
particular
present
appear
literatur
may
consid
exampl
help
avoid
misdiagnosissever
year
ago
lidov
et
al
describ
woman
promin
lymphoid
infiltr
lachrym
salivari
gland
associ
pituitari
dysfunct
laboratori
imag
find
allow
diagnosi
lyh
show
dramat
respons
steroid
appar
complet
recoveri
instead
year
later
grave
diseas
develop
requir
appropri
prolong
therapi
case
autoimmun
process
follow
region
tissu
distribut
includ
pituitari
thyroid
lachrym
salivari
gland
usual
mri
lyh
show
pituitari
enlarg
symmetr
extrasellar
expans
homogen
hyperintens
signal
gadolinium
extend
sometim
basal
hypothalamu
tonguelik
fashion
stalk
thicken
deviat
instead
pereznunez
et
al
describ
interest
case
patient
lyh
present
mri
cystic
lesion
ring
contrast
enhanc
sinc
appear
imag
studi
unusu
consid
among
possibl
featur
suggest
diseas
appropri
clinic
contexthuang
et
al
describ
man
suffer
prolong
fever
month
without
clinic
evid
infect
pituitari
insuffici
diagnos
appropri
endocrin
investig
whole
bodi
imag
studi
mm
mass
lesion
sella
turcica
identifi
could
suggest
diagnosi
lyh
patholog
investig
reveal
mass
infiltr
blymphoid
cell
howev
spite
time
subtot
tumor
resect
steroid
supplement
induc
gradual
fever
remiss
mass
invad
cavern
sinu
optic
chiasma
shortli
surgeri
metastat
lesion
liver
left
adren
gland
retroperiton
lymph
node
discov
month
later
contrast
cell
pituitari
liver
biopsi
reveal
liver
mass
exclus
cell
origin
author
conclud
case
exemplifi
rare
note
condit
primari
lymphoma
concomit
hypophys
whose
clinic
diagnosi
indiscern
occurr
system
tumor
metastasi
leow
et
al
perform
interest
studi
investig
chronic
endocrin
sequela
survivor
sever
acut
respiratori
syndrom
sar
patient
analys
hormon
derang
month
follow
recoveri
twenthyfour
patient
evid
hypocortisol
associ
subclin
transient
subclin
thyrotoxicosi
two
central
hypothyroid
four
hpa
axi
dysfunct
major
resolv
within
year
result
highlight
possibl
etiolog
role
sarsassoci
coronaviru
caus
revers
hypophys
hpa
axi
frequent
affect
associ
thyoid
autoimmun
diseas
among
ap
type
recent
three
interest
case
publish
kanok
el
al
present
hypophys
spread
outsid
pituitari
tissu
cavern
sinu
rare
describ
spread
diagnosi
lyh
verifi
three
case
pituitari
transphenoid
surgeri
two
three
case
fulfil
histolog
criteria
hypophys
although
none
high
serum
level
case
exampl
unusu
spread
hypophys
nearbi
organ
paper
five
case
hypophys
spread
cavern
sinu
publish
case
lyh
present
temperatur
dysregul
recent
publish
first
case
jain
dhanwa
present
document
bodi
temperatur
oscil
hoars
voic
sexual
dysfunct
panhypopituitar
elev
titr
antitpo
postur
hypotens
typic
find
lyh
mri
prednison
therapi
along
hormon
replac
therapi
induc
recoveri
normal
rhythm
temperatur
previou
alter
within
daysth
second
case
describ
complex
associ
postpartum
hypothermia
hypoglicemia
hypoadren
hypothyroid
accompani
characterist
find
mri
follow
result
author
suggest
practition
keep
mind
possibl
lyh
pregnant
women
symptom
hypoglicemia
hypothermia
deliveri
ruptur
rathk
cleft
cyst
may
caus
lymphocyticinfundibuloneurohypophys
two
case
publish
hayashi
et
al
present
visual
disturb
headach
endocrin
insuffici
follow
diabet
insipidu
two
rare
case
lymphocyticinfundibuloneurohypophys
confirm
postsurgeri
patholog
examin
show
massiv
lymphocyt
infiltr
cyst
wall
posterior
lobe
specif
characterist
possibl
autoimmun
hypophys
may
also
observ
patient
late
phase
complet
select
hypopituitar
patient
sheehan
syndrom
hypopituitar
occur
year
brain
injuri
meningoenceph
children
celiac
diseas
short
statur
show
signific
increas
statur
glutenfre
diet
diseas
search
apa
immunofluoresc
may
help
disclos
pituitari
autoimmun
differ
express
autoimmun
diseas
requir
differ
therapeut
strategi
even
possibl
spontan
remiss
natur
histori
lyh
occur
reason
first
care
followup
advis
patient
without
symptomat
extrasellar
expans
import
hypoadren
therapeut
option
must
differ
acut
chronic
phase
acut
phase
glucocorticoid
replac
stress
dose
mandatori
patient
acut
adren
insuffici
phase
surgic
option
transsphenoid
surgeri
may
necessari
patient
symptom
andor
sign
sever
compress
even
possibl
reduct
pituitari
mass
volum
high
dose
methylprednisolon
gday
day
follow
taper
dose
may
observ
immunosuppress
drug
includ
azathiopirin
methotrex
cyclosporin
also
use
success
particularli
corticosteroidresist
case
longterm
efficaci
still
need
confirm
therapeut
strategi
chronic
phase
aim
restor
adequ
hormon
level
affect
patient
appropri
replac
therapi
recov
secondari
hypoadren
hypogonad
hypothyroid
gh
defici
present
due
lyh
per
se
result
neurosurg
therapi
dopamin
agonist
bromocriptin
cabergolin
lower
hyperprolactinemia
improv
visual
field
alter
case
impact
cours
diseas
still
discuss
howev
well
known
high
level
prl
contribut
perpetu
immun
process
lyh
proinflammatori
immunogen
effect
hormon
also
recent
demonstr
hyperprolactinemia
relat
prolacinoma
may
increas
preval
autoimmun
diseas
mainli
thyroid
diseas
thu
normal
prolactin
level
dopamin
agonist
hypeprolactinem
patient
lyh
advis
prevent
possibl
autoimmun
involv
thyroid
endocrin
gland
recent
studi
outcom
main
treatment
option
lyh
conduct
german
patient
compar
outcom
differ
option
result
show
glucocorticoid
puls
therapi
associ
high
recurr
rate
moreov
evid
suggest
surgeri
abl
prevent
recurr
author
conclud
consid
favour
result
observ
conserv
manag
recommend
lyh
unless
symptom
sever
progress
recent
rituximab
rtx
monoclon
antibodi
lyze
b
cell
express
usual
employ
treatment
sever
autoimmun
diseas
employ
treat
singl
case
steroidrefractori
lyh
abl
induc
remiss
case
isol
lyh
case
lyh
associ
immun
thrombocytemia
within
polyendocrin
syndrom
type
thu
rtx
could
consid
among
new
therapeut
option
treatment
type
ap
includ
lyh
provid
result
support
studi
larg
popul
recent
good
respons
immunotherapi
base
sequenti
use
infliximab
monoclon
antibodi
antagon
tumor
necrosi
factor
alpha
rtx
obtain
woman
present
lyh
occur
triad
scleriti
uveiti
optic
neuriti
open
new
therapeut
horizon
lyh
